Searchable abstracts of presentations at key conferences in endocrinology

ea0094p299 | Thyroid | SFEBES2023

Amiodarone induced thyrotoxicosis type 1 (AIT1) without Graves’ disease or toxic nodular goitre

narayanan Mannath Sathia , Sudarshanan Aditya , Fernandez James Cornelius

Introduction: AIT1 usually occur on a background of Graves’ disease or toxic nodule goitre. The disease usually requires higher doses of carbimazole than Graves’, might need rescue thyroidectomy, and can be treated with radioiodine with higher than standard radioiodine doses after iodine contamination has come down.Case Presentation: 57-year-old gentleman with history of HTN, T2DM, dyslipidemia, aortic stenosis...

ea0095p5 | Adrenal 1 | BSPED2023

Retrospective review of patients with 21-hydroxylase deficiency (21OHD) Congenital adrenal hyperplasia (CAH) in a tertiary children’s hospital

Riches Katherine , Abey Rose , Denvir Louise , Law James , Sachdev Pooja

Background: The most common form (90%) of CAH is 21-hydroxylase deficiency (21OHD). Management is with hydrocortisone ±fludrocortisone replacement while minimising side effects of androgen excess. Our aim was to review our CAH cohort and describe their characteristics, treatment regimens and growth.Methods: Retrospective data on height, weight, BMI, bone age and biochemical profiles was collected on 26 patients with...

ea0094p5 | Adrenal and Cardiovascular | SFEBES2023

Salivary Steroid Profile: the simultaneous quantification of androgens, glucocorticoids, and mineralocorticoids in human saliva

Bain Joshua , Gilligan Lorna , Hawley James , Taylor Angela

Steroid profiling of biological fluids has been used for clinical and diagnostic research since the 1950s. Most methods focus on blood and urine, however, more recently saliva analysis has been employed as a non-invasive, simple to collect sample for the diagnosis of conditions such as Cushing’s and androgen excess. Despite its ease of collection, saliva remains an underutilised biofluid. To investigate the use of salivary steroid profiling for endocrine research, we aimed to ...

ea0098c35 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023

Institutional retrospective review of peptide receptor radionuclide therapy use in metastatic paragangliomas and pheochromocytomas

Lan Wong PA-C, Yee , MD, PhD. James Thomas

Background: Metastatic paragangliomas (PGL) and pheochromocytomas (PCC) are rare neuroendocrine diseases with an incidence of 2 to 8 people per million, a prevalence between 1:2500 and 1:6500 and a strong hereditary disposition. However, due to the rarity of the disease, there is relatively limited data on treatment options, including radionuclide therapy using radioisotope analogs of MIBG and dotatate. There are a few published small series on clinical benefits of treating PG...

ea0099rc13.4 | Rapid Communications 13: Late Breaking | ECE2024

Development and validation of an LC-MS/MS method to measure 7-alpha-hydroxy-4-cholesten-3-one (C4) for the assessment of bile acid dysregulation in PCOS

Atkins Jonathan S , Keevil Brian , Ludwig Christian , Hawley James M.

Introduction: 7α-Hydroxy-4-cholesten-3-one (C4) is the common intermediary of the primary bile acids (BAs). Its concentration in serum correlates with the rate of activity of hepatic CYP7A1 and therefore with the rate of hepatic BA production. Previous work has smggested a role for BA pool dysregulation in the metabolic syndrome and gut dysbiosis seen in polycystic ovary syndrome (PCOS). However, the mechanism of this is still to be elucidated. Here we report a novel LC-M...

ea0013oc38 | British Thyroid Association Award | SFEBES2007

The novel thyroid hormone derivative 3-iodothyronamine increases food intake via the hypothalamic arcuate nucleus

White Nicholas , Dhillo Waljit , Bewick Gavin , Gardiner James , Scutt James , Thompson Emily , Kokkinos Alexander , Armstrong Alan , Ghatei Mohammad , Bloom Stephen

3-iodothyronamine (T1AM) is a novel, endogenous rapid acting biogenic amine, which is a potent agonist of the G-protein coupled trace amine-associated receptor 1, TAAR1. It has been suggested that endogenous T1AM could be generated by enzymatic deiodonation and decarboxylation of T4. The presence of T1AM in rat brain and the distribution of the TAAR1 receptor in the hypothalamus suggest that T1AM may affect food intake and regulate e...

ea0013p202 | Endocrine tumours and neoplasia | SFEBES2007

Impact of the implementation of European consensus guidelines on the management of differentiated Thyroid Cancer

Waldron-Lynch Frank , Gallagher Joe , Geraghty James , Kinsella John , Jeffers Michael , Thirion Pierre , Barragry John , Gibney James

Thyroid cancer is the commonest endocrine malignancy. Recently, a European consensus statement for the management of patients with differentiated thyroid carcinoma has been published1. The diagnostic and follow up protocols differ from previous guidelines by the use of neck ultrasound and recombinant human thyroglobulin (rhTSH) measurements. The aim of this study was to determine the current management of suspicious thyroid nodules and the follow up of thyroid cance...

ea0077op3.3 | Reproductive and Neuroendocrinology | SFEBES2021

‘Suppression imaging’ – a novel PET technique for increasing confidence in the localisation of secretory pituitary microadenomas

MacFarlane James , Kourlouri Olympia , Gillett Daniel , Senanayake Russell , Santarius Thomas , Tysome James , Donnelly Neil , Mendichovszky Iosif , Cheow Heok , Mannion Richard , Bashari Waiel , Gurnell Mark

Background: In a sub-group of patients with newly diagnosed pituitary adenomas, conventional MRI will fail to confidently localise the tumour. The role of molecular imaging for these patients is increasingly being recognised, both in terms of confirming diagnosis and in guiding targeted therapy; 11C-Methionine PET co-registered with volumetric MRI (Met-PET/MRCR) can enhance decision making in this group of patients. However, in some cases distinguishing t...

ea0050p320 | Obesity and Metabolism | SFEBES2017

Androgen excess is highly prevalent in women with idiopathic intracranial hypertension and is biochemically distinct from polycystic ovary syndromes

O'Reilly Michael , Hornby Catherine , Westgate Connar , Botfield Hannah , Markey Keira , Mitchell James , Jenkinson Carl , Gilligan Lorna , Sherlock Mark , Gibney James , Tomlinson Jeremy , Arlt Wiebke , Sinclair Alexandra

Idiopathic intracranial hypertension (IIH) is a condition of unknown aetiology characterised by raised intracranial pressure, chronic headaches and blindness. Akin to polycystic ovary syndrome (PCOS), IIH patients are almost exclusively obese females of reproductive age. A distinct androgen excess profile has been noted in PCOS. Here, we aimed to delineate androgen metabolism in IIH compared to PCOS and simple obesity.Women w...

ea0050p320 | Obesity and Metabolism | SFEBES2017

Androgen excess is highly prevalent in women with idiopathic intracranial hypertension and is biochemically distinct from polycystic ovary syndromes

O'Reilly Michael , Hornby Catherine , Westgate Connar , Botfield Hannah , Markey Keira , Mitchell James , Jenkinson Carl , Gilligan Lorna , Sherlock Mark , Gibney James , Tomlinson Jeremy , Arlt Wiebke , Sinclair Alexandra

Idiopathic intracranial hypertension (IIH) is a condition of unknown aetiology characterised by raised intracranial pressure, chronic headaches and blindness. Akin to polycystic ovary syndrome (PCOS), IIH patients are almost exclusively obese females of reproductive age. A distinct androgen excess profile has been noted in PCOS. Here, we aimed to delineate androgen metabolism in IIH compared to PCOS and simple obesity.Women w...